59 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof" positions at University of Lund
Sort by
Refine Your Search
-
Description of the workplace The Department of Immunotechnology conducts research ranging from advanced technology development to biomedical studies. The main research areas include immuno-oncology
-
, generation of attosecond pulses and applications of these to the study of ultrafast phenomena in various systems. We are looking for one to three postdocs to develop attosecond pulse sources and to study
-
level within various branches of biotechnology. One of the important areas is industrial biotechnology, which involves the development of biological catalysts and sustainable processes for bio-based
-
, procurement and commissioning of equipment. Together with your colleagues, you will contribute to developing and maintaining a proactive and integrated safety culture at MAX IV. Would you like to work at one
-
and construction. As part of this activity, consideration of safety aspects and development of methods for dealing with dangers in society is also included. The width of such safety-related research
-
overarching view of the beamline instruments as well as coordinate and execute beamline operation, commissioning, maintenance and further development of Balder beamline together with the Balder team. Your main
-
the early development of telecommunications to the space race. Today, driven by the need to engineer ever larger systems, Automatic Control has never been more relevant. The department has a stimulating and
-
protein research to develop new biomarkers for earlier diagnosis and treatment response. Within the research group, we value a good work environment based on respect and care in our interactions with one
-
equality and diversity as a strength and an asset. Subject description The research will focus on the development of novel radical-based transformations aimed at expanding chemical space and enabling
-
, supporting structural biology research aiming at understanding biology at a molecular level with applications in drug development and biotechnology. BioMAX is in user operation since 2017 with world class